Flow cytometry is a powerful laser-based analytical technique used in various fields including medical diagnosis, immunology, and biotechnology. It allows for the characterization of particles such as cells and quantification of multiple physical and chemical characteristics of individual particles as they flow in a fluid stream through a beam of laser light. Properties such as cell size, cell granularity, and the presence or amounts of cell surface markers or intracellular proteins can be detected using flow cytometry. This has made it a valuable technique for health research, disease diagnosis and monitoring treatment response.
Some key applications of flow cytometry include detecting and counting various blood cell types, detecting and monitoring certain cancers like leukemia based on cell surface markers, characterization of immune cell subsets based on various receptor expression, detecting cell viability and apoptosis, measuring calcium fluxes or pH within cells, quantifying the expression levels of various cell surface receptors, intracellular proteins, DNA and RNA molecules. It is routinely used in basic and clinical immunology research to characterize and quantify lymphocyte populations such as T cells, B cells, and their various subsets. Flow cytometry is commonly employed to detect circulating tumor cells, and characterize prognostic and predictive biomarkers on cancer cells. Besides research applications, it is widely used in clinical diagnostics and disease monitoring in areas like hematology, oncology, and immunology.
Research Over the Years: Since its inception in the late 1960s, flow cytometry has evolved significantly. Early instruments had limited sensitivity and could detect only a few parameters simultaneously. Technological advancements now allow for detection of over 20 parameters in a single cell, enabling in-depth multi-parametric analysis of complex biological systems. The development of excitation lasers that emit light at different wavelengths, new fluorochrome conjugated antibody panels, and advanced electronics and software have revolutionized what can be measured on individual cells using this technique. Flow cytometers are now available that can analyze over thousands of events per second with high resolution. Cell sorting attachments enable isolation of viable cell populations for downstream applications like gene expression analysis.
Multi-color flow cytometry has become an indispensable tool in immunological research over the past few decades. It has helped uncover new immune cell subsets and subtypes, decipher signaling pathways, elucidate mechanisms of immune cell development, differentiation and function, study leukocyte trafficking and cellular interactions. Flow cytometry based techniques have been integral to discoveries related to innate and adaptive immunity, development of vaccines, monoclonal antibody therapeutics, understanding of autoimmune diseases, transplant immunology and more. Combining flow cytometry with other innovative technologies like mass cytometry further expands the scope of simultaneous measurements and discoveries.
Basic and translational cancer research has also benefited enormously from advances in flow cytometry. Better understanding of tumor immunology, tumor microenvironment, circulating tumor cells, cancer stem cells and heterogeneity within tumors has been facilitated by multi-parametric flow cytometric analysis. Clinical oncology research relies on flow cytometry for biological assays to develop and evaluate prognostic and predictive biomarkers, determine appropriate immunotherapy targets, and assess response to treatment. Screening of new anti-cancer therapeutics depends on flow cytometry based assays of mechanisms of drug action, toxicity and efficacy. Stem cell and developmental biology research also leverage the strength of flow cytometry for lineage tracking, viability assays, detection of surface markers and intracellular proteins during differentiation.
Flow Cytometry Research Papers: Flow cytometry has been the subject of numerous high impact primary research and review articles over the years spanning its wide applications. Here are some examples of peer reviewed research papers that showcase the potential of flow cytometry:
A 2021 review paper published in Cytometry Part A evaluated advances in flow cytometry that have enabled multi-parametric analysis of 30 parameters on single cells. It discussed technological improvements, applications in systems immunology and systems biology research.
A 2020 research article in Cancer Research characterized circulating tumor cells in lung cancer using a high-dimensional flow cytometry-based assay. It correlated CTC subpopulations with prognosis and identified potential targets for treatment.
A 2018 article in the Journal of Clinical Investigation used mass cytometry to define immune cell states in lung cancer microenvironment and their association with prognosis. It provided new insights into immune suppression mechanisms.
A 2016 paper in Blood described a 17-color flow cytometry assay to comprehensively profile lymphocyte phenotypes. It helped delineate ontogeny of innate-like B cells and identify phenotypic signatures associated with autoimmunity.
A 2014 paper in Science Translational Medicine analyzed over 60 attributes of acute myeloid leukemia cells using a 29-parameter flow cytometric assay. It identified immunophenotypic clusters with distinct clinical outcomes requiring customized therapy.
A landmark 2001 Nature Immunology study used 11-color flow cytometry to characterize unique phenotypes of various human dendritic cell subsets and map their localization in secondary lymphoid tissues.
Flow cytometry remains a powerful analytical technique driving discoveries across biology and medicine. Technological advancements continue to expand its applications. Combined with other ‘omics approaches, it provides a robust systems level understanding of complex cellular systems and diseases. Flow cytometry will remain a mainstay of immunological, cancer and stem cell research in the coming decades.
Andrew Stroud